Monographie - Bortezomib

Poslední aktualizace :
19/11/2024

Bortezomib

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bemoncaz	Meksikas
Bicavan	Čilė
Biemib	Turkija
Bomib	Meksikas
Borater	Argentina
Borcade	Turkija
Bormib	Argentina
Bortezomib	Naujojoje Zelandijoje
Bortezun	Ekvadoras
Bortrac	Ekvadoras, Peru
Bortzo	Peru
Botemib	Čilė, Ekvadoras, Peru
Bozix	Čilė, Peru
Bozob	Argentina, Ekvadoras, Peru
Bromadene	Argentina
Egybort	Indija
Elomaziv	Meksikas
Gysatri	Argentina
Miasoma	Argentina
Mibor	Peru
Multizom	Argentina
Rebtik	Čilė
Velcade	Airija, Argentina, Australija, Austrija, Belgija, Čilė, Danija, Didžioji Britanija, Egiptas, Graikija, Islandija, Ispanija, Italija, Japonija, Jungtinės Amerikos Valstijos, Jungtiniai Arabų Emyratai, Kanada, Kolumbija, Lenkija, Liuksemburgas, Malaizija, Meksikas, Naujojoje Zelandijoje, Norvegija, Olandija, Portugalija, Prancūzija, Rumunija, Saudo Arabija, Suomija, Švedija, Šveicarija, Turkija, Venesuela, Vengrija, Vokietija
Velcord	Peru
Vortemyel	Rumunija
Zefra	Argentina
Zegomib	Rumunija
Zuricade	Meksikas

Bibliografija : Bortezomib

	tipas	leidinys
1911	Laboratorija	Bortezomib (Velcade®) - Summary of Product Characteristics Janssen-Cilag Ltd 2016
2010	Žurnalas	André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE. Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial. Ann Pharmacotherapy 2005 ; 39: 1462-1466.
2011	Žurnalas	Friess D, Nguyen HC, Lipp HP. HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen. Krankenhauspharmazie 2005 ; 26, 6: 206-210.
2232	Žurnalas	Walker SE, Milliken D, Law S. Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C) Can J Hosp Pharm 2008 ; 61, 1: 14-20.
3190	Žurnalas	Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M, An NMR Study of the Bortezomib Degradation under Clinical Use Conditions. Advance in Haematology 2009 Article ID 704928, 5 page
3240	plakatas	Perissutti M, Vigneron J, Zenier H, May I, Demoré B. Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène. Congrès SFPO 2011
3337	Žurnalas	Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature. EJHP 2012 ; 19: 428-431.
3349	Žurnalas	Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M. Chemical stability of bortezomib solutions in original manufacturer vials. Int J Pharm Bio Sci 2012 ; 2, 3: 344-350.
3418	Žurnalas	Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C. Int J Pharm Bio Sci 2013 ; 3, 1: 449-458.
3447	plakatas	Giovanelli M, Vigneron J, May I, Nicolas A. Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière. SFPO Congress, Mandelieu, France 2013
3537	Žurnalas	Lipp HP, Gfrörer W, Riedmüller S. Bortezomib zur subkutanen Applikation. Krankenhauspharmazie 2013 ; 34,11: 500-505.
3688	Žurnalas	Walker S.E, Charbonneau L.F, Law S. Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C). Can J Hosp Pharm 2014 ; 67, 2: 102-107
4137	Žurnalas	Patel T, Sewell G. Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare). Newsletter Stabilis 2018 41;2-6
4485	Žurnalas	Law S, Charbonneau L, Iazetta J, Perks W, Ma N, Walker S.E. Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C) Can J Hosp Pharm 2021 ;74;1:57-69

Mentions Légales